- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Orocobre Successfully Completes Dual Listing on Toronto Stock Exchange
Orocobre (the Company) (TSX:ORL)(ASX:ORE) advised that the Company has been admitted to the Toronto Stock Exchange and has dual listed its ordinary shares on the TSX under the ticker symbol “ORL”.
Orocobre (the Company) (TSX:ORL)(ASX:ORE) advised that the Company has been admitted to the Toronto Stock Exchange and has dual listed its ordinary shares on the TSX under the ticker symbol “ORL”.
The press release is quoted as saying:
The Company will continue to be domiciled in Australia and its ordinary shares will continue to trade on the Australian Securities Exchange. Admission to the TSX is an important milestone in the development of Orocobre and is designed to increase exposure of the Company and its projects to North American investors.
Click here to access the entire press release
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.